PICI Advances Precision T Cell Engineering for Prostate Cancer
Parker Institute for Cancer Immunotherapy/LinkedIn

PICI Advances Precision T Cell Engineering for Prostate Cancer

Parker Institute for Cancer Immunotherapy (PICI) shared on X:

“In honor of Prostate Cancer Awareness Month, we’re putting the spotlight on research across the Parker Institute for Cancer Immunotherapy network, including a new approach to engineering more powerful cancer-fighting cells.

Parker Institute for Cancer Immunotherapy Center Co-Director Owen N. Witte, and researcher Christopher Garcia, developed a new way to engineer T cells to better recognize and attack prostate cancer while sparing healthy cells.”

Read the full artickle

Cancer and the Brain: How Tumors Hijack Neural Signals to Fuel Tumor Growth

PICI Advances Precision T Cell Engineering for Prostate Cancer